|
Objecti ve To observe the clinical efficacy of the fourth prescription in Shirc lun in the recovery phase post-stroke (shirexiefeng Style) through randomized,controlled clinical study.MethodsSelect60patients who were diagnosed in in the recovery phase post-stroke (shirexiefeng Style)(duration1-3months)in the Neuro-logy outpatient deparment of Hubei Hospital.They were randomly divided into the treatment and control group, each group had30cases. The basic treatments were same in the groups, while the fourth prescription in Shire lun was given twice each day in the treatment goup. Two weeks is a course, f our courses were observed.In each course, the Motor Assessment Scores, TCM syndrome scores and clinicalefficacy were compared respectively.Results1. The Baseline Characteristics, Moter Assessment Scores, TCM syndrome scores were comparable in the two groups, ther e was no significnat differences (P>0.05)2. In two weeks, four weeks, six weeks and eight weeks, The Moter Assessment Scores was16.40±2.54,18.07±2.79,19.90±2.70,21.13±2.65in the treatment group, while15.17±1.97,16.63±2.02, 17.77±1.92,18.50±1.93in the control group. The Moter Assessment Scores of the two groups in two weeks, four weeks, six weeks and eight weeks was higher than the basline scores (P<0.05); The Moter Assessment Scores in the treatment group in two weeks, four weeks, six weeks and eight weeks was higher than the control group (P<0.05).3. In two weeks,four weeks, six weeks and eight weeks, The TCM syndrome scores in the treatment group was13.76±1.65,12.07±1.17,11.03±1.09,8.43±1.43,7.80±1.24; while14.60±1.81,13.36±1.77,12.13±1.41,9.97±1.69,9.10±1.37in the control goup. The TCM syndrome scores of the two groups in two weeks, four weeks,six weeks and eight weeks was higher than the basline scores (P<0.05); The TCM syndrome scores in the treatment group in two weeks, four weeks, six weeks and eight weeks was higher than the control group (P<0.05).4. The total effective rate was80%and53.33%in the treatment and control group in two weeks, respectively, having significant differences (x2=4.8, P=0.028); The total effective rate was86.67%and60%in the treatment and control group in four weeks,Respect-ively, having significant differences (x2=5.455, P=0.02); the total effective rate was90%and63.33%in the treatment and control group in six weeks, respectively,having significant differences (x2=5.963, P=0.015); the total effective rate was93.33%and70%in the treatment and control group in eight weeks, respectively, having significant differences (x2=5.455, P=0.02).Conclusions1. The fourth prescription in Shire lun can improve the limb function in the recovery phase post-stroke(shirexiefeng Style). 2. The fourth prescription in Shire lun can improve the TCM syndrome scores in the recovery phase post-stroke(shirexiefeng Style).3. The fourth prescription in Shire lun is clinical effetive in the recovery phase post-stroke (shirexiefeng Style).
|